These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6118086)

  • 1. [Clinical evaluation of pipothiazine and its palmitic ester in the therapy of schizophrenia].
    Costa JG; Silva E; Dreyfus JF
    Ann Med Psychol (Paris); 1981 Apr; 139(4):439-45. PubMed ID: 6118086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pipotiazine palmitate: an evaluation of a new long acting intramuscular antipsychotic agent in severely ill schizophrenic patients.
    Gallant DM; Mielke D; Bishop G; Oelsner T; Guerrero-Figueroa R
    Dis Nerv Syst; 1975 Apr; 36(4):193-6. PubMed ID: 1090427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Initial results of a pharmacokinetic study of pipothiazine and its palmitic ester (Piportil L4) in a schizophrenic population].
    Girard M; Granier F; Schmitt L; Cotonat J; Escande M; Blanc M
    Encephale; 1984; 10(4):171-6. PubMed ID: 6149927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depot pipotiazine 1970-1982: a review.
    Burch EA; Ayd FJ
    J Clin Psychiatry; 1983 Jul; 44(7):242-7. PubMed ID: 6134718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses.
    Salvesen C; Vaksdal K
    PDM; 1974; 5-6(9-12;1-8):10-4. PubMed ID: 4156935
    [No Abstract]   [Full Text] [Related]  

  • 6. A versatile new sustained-action neuroleptic: pipotiazine palmitate in psychiatric practice.
    Johnston RE; Niesink F
    J Int Med Res; 1979; 7(3):187-93. PubMed ID: 37133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncontrolled study with pipothiazine palmitate.
    Jain RC; Ananth JV; Klingner A; Ban TA; Lehmann HE
    Int J Clin Pharmacol; 1973 Feb; 7(1):32-6. PubMed ID: 4699381
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.
    Buckley PF
    Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piperacetazine in ambulatory chronic schizophrenic patients.
    Rada RT; Donlon PT
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of severe psychotic outbreaks by short-interval injection of pipothiazine undecylenate].
    Tignol J; Dartigues JF; Daubech JF; Bourgeois M
    Ann Med Psychol (Paris); 1979; 137(3-4):345-51. PubMed ID: 40513
    [No Abstract]   [Full Text] [Related]  

  • 11. [Influence of pipotiazine on schizophrenia].
    Sevestre P; Coloni F; Lagrange J
    Encephale; 1978; 4(1):61-70. PubMed ID: 26560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pipothiazine (piportil) in the treatment of various forms of schizophrenia].
    Matkowski K; Sep-Kowalikowa B
    Psychiatr Pol; 1979; 13(4):421-3. PubMed ID: 42095
    [No Abstract]   [Full Text] [Related]  

  • 13. Initial treatment of severe acute psychosis with fast orally disintegrating risperidone tablets.
    Normann C; Schmauss M; Bakri N; Gerwe M; Schreiner A
    Pharmacopsychiatry; 2006 Nov; 39(6):209-12. PubMed ID: 17124642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes.
    Dolzan V; Serretti A; Mandelli L; Koprivsek J; Kastelic M; Plesnicar BK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1562-6. PubMed ID: 18573584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary experience in the treatment of schizophrenia with pipothiazine and its derivatives.
    Faltus F; Marecek P; Soucek K
    Act Nerv Super (Praha); 1975 Sep; 17(3):204. PubMed ID: 883
    [No Abstract]   [Full Text] [Related]  

  • 16. Pipotiazine palmitate: a new depot neuroleptic.
    Simpson GM; Varga V
    Curr Ther Res Clin Exp; 1975 Mar; 17(3):276-80. PubMed ID: 236151
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiences with depot-neuroleptics in an after-care unit. Organization of the therapy exemplified with pipotiazine palmitate].
    Salvesen C; Vaksdal K
    Tidsskr Nor Laegeforen; 1973 Aug; 93(24):1699-703. PubMed ID: 4149082
    [No Abstract]   [Full Text] [Related]  

  • 18. An uncontrolled clinical study with piperacetazine in the maintenance treatment of chronic schizophrenic patients.
    Amin MM; Brahm E; Ban TA; Lehmann HE
    Psychopharmacol Bull; 1977 Jul; 13(3):10-1. PubMed ID: 18753
    [No Abstract]   [Full Text] [Related]  

  • 19. High dosage piperacetazine (Quide) in ambulatory schizophrenic patients--therapeutic efficacy and toxicity.
    Donlon PT; Rada RT
    Dis Nerv Syst; 1974 May; 35(5):231-6. PubMed ID: 17894106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acutely ill schizophrenic patients treated with loxapine. A clinical study in a community mental health center.
    Rasul M
    Clin Ther; 1980; 3(4):242-9. PubMed ID: 7273062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.